Edgestream Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.97M Buy
133,766
+51,498
+63% +$2.44M 0.18% 194
2026
Q1
$4.24M Buy
82,268
+64,315
+358% +$4.5M 0.14% 285
2025
Q4
$1.66M Sell
17,953
-5,003
-22% -$479K 0.05% 581
2025
Q3
$1.7M Sell
22,956
-37,242
-62% -$3.77M 0.05% 566
2025
Q2
$7.81M Buy
60,198
+55,761
+1,257% +$8.09M 0.22% 157
2025
Q1
$707K Buy
+4,437
New +$803K 0.02% 658
2024
Q1
Sell
-2,760
Closed -$561K 912
2023
Q4
$561K Sell
2,760
-1,110
-29% -$180K 0.04% 585
2023
Q3
$768K Buy
3,870
+3,060
+378% +$772K 0.06% 477
2023
Q2
$263K Buy
+810
New +$231K 0.02% 649

Other funds holding INSP

Edgestream Partners's INSP Position: Q2 2026 in Review

Edgestream Partners increased its Inspire Medical Systems (INSP) stake by 63% in Q2 2026, buying an estimated $2.44M and bringing the position to 133,766 shares worth $5.97M. The position accounts for 0.18% of the portfolio, ranked #194.

Edgestream Partners first reported a position in INSP in Q2 2023 and has held it in 9 quarters since. The position peaked at $7.81M in Q2 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Edgestream Partners held 133,766 shares of Inspire Medical Systems worth $5.97M as of Q2 2026.
  • Edgestream Partners bought 51,498 Inspire Medical Systems shares in Q2 2026, an estimated $2.44M.
  • Inspire Medical Systems made up 0.18% of Edgestream Partners's portfolio in Q2 2026, its #194 holding.
  • Edgestream Partners first reported a position in Inspire Medical Systems in Q2 2023 and has held it in 9 quarters since.
  • Edgestream Partners's Inspire Medical Systems position peaked at $7.81M in Q2 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.